Views & Analysis IBM Watson: a holistic approach to health Kyu Rhee, chief health officer, speaks about the company's impact and aspirations in health.
Views & Analysis Artificial intelligence: the way ahead for pharma What has been its impact on the pharma and healthcare sectors?
Views & Analysis Digital Health Round-up – new President, new ideals? A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Janssen licenses drugs to artificial intelligence company BenevolentAI's Judgment Augmented Cognition System will help develop the new drugs.
Views & Analysis Digital Health Round-up: Fitbit falters, NHS picks six winne... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Celgene and IBM Watson look to improve patient safety Watson for Patient Safety will help improve understanding of drug safety profiles.
Oncology ESMO 2024 - Henar Hevia & Carolyn Sousa ESMO 2024 was chock full of oncological data, diverse presentations providing hope across the cancer spectrum from breast and lung to unmet needs in colorectal and bladder.
R&D Sponsored Beyond clinical: Boosting recruitment and retention with SDO... The success of clinical trials hinges on a complex array of factors, many of which extend beyond traditional clinical care.